JAMES RYAN: Open Payments
NPI 1831493196 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 45 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $182 |
| Janssen Pharmaceuticals, Inc | 8 | $166 |
| ABBVIE INC. | 5 | $163 |
| Alkermes, Inc. | 7 | $154 |
| Teva Pharmaceuticals USA, Inc. | 6 | $110 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: CAPLYTA, INVEGA SUSTENNA, VRAYLAR, ARISTADA, AUSTEDO XR, HETLIOZ, UZEDY, FANAPT.
Industry payments across KY — which companies pay providers there.
